Integrin-based therapeutics: biological basis, clinical use and new drugs

K Ley, J Rivera-Nieves, WJ Sandborn… - Nature reviews Drug …, 2016 - nature.com
Integrins are activatable molecules that are involved in adhesion and signalling. Of the 24
known human integrins, 3 are currently targeted therapeutically by monoclonal antibodies …

Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines

JW Eikelboom, J Hirsh, FA Spencer, TP Baglin, JI Weitz - Chest, 2012 - Elsevier
The article describes the mechanisms of action, pharmacokinetics, and pharmacodynamics
of aspirin, dipyridamole, cilostazol, the thienopyridines, and the glycoprotein IIb/IIIa …

[HTML][HTML] Pathophysiology and diagnosis of drug-induced immune thrombocytopenia

C Vayne, EA Guéry, J Rollin, T Baglo… - Journal of clinical …, 2020 - mdpi.com
Drug-induced immune thrombocytopenia (DITP) is a life-threatening clinical syndrome that
is under-recognized and difficult to diagnose. Many drugs can cause immune-mediated …

Idiosyncratic adverse drug reactions: current concepts

J Uetrecht, DJ Naisbitt - Pharmacological reviews, 2013 - ASPET
Idiosyncratic drug reactions are a significant cause of morbidity and mortality for patients;
they also markedly increase the uncertainty of drug development. The major targets are skin …

Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

C Patrono, B Coller, GA FitzGerald, J Hirsh, G Roth - Chest, 2004 - Elsevier
This article discusses platelet active drugs as part of the Seventh American College of Chest
Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based …

Drug-induced immune thrombocytopenia

RH Aster, DW Bougie - New England Journal of Medicine, 2007 - Mass Medical Soc
Drug-induced thrombocytopenia should be suspected in any patient with acute
thrombocytopenia of unknown cause. Although the incidence is low, more than 100 drugs …

Integrins: dynamic scaffolds for adhesion and signaling in platelets

SJ Shattil, PJ Newman - Blood, 2004 - ashpublications.org
The major platelet integrin, αIIbβ3, is required for platelet interactions with proteins in plasma
and the extracellular matrices (ECMs) that are essential for platelet adhesion and …

[HTML][HTML] Integrins as therapeutic targets: successes and cancers

S Raab-Westphal, JF Marshall, SL Goodman - Cancers, 2017 - mdpi.com
Integrins are transmembrane receptors that are central to the biology of many human
pathologies. Classically mediating cell-extracellular matrix and cell-cell interaction, and with …

Antiplatelet drugs: American College of Chest Physicians evidence-based clinical practice guidelines

C Patrono, C Baigent, J Hirsh, G Roth - Chest, 2008 - Elsevier
This article about currently available antiplatelet drugs is part of the Antithrombotic and
Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical …

[HTML][HTML] Structure and function of the platelet integrin αIIbβ3

JS Bennett - The Journal of clinical investigation, 2005 - Am Soc Clin Investig
The platelet integrin αIIbβ3 is required for platelet aggregation. Like other integrins, αIIbβ3
resides on cell surfaces in an equilibrium between inactive and active conformations …